Literature DB >> 32873704

Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.

Ryan P Staudt1, Thomas E Smithgall2.   

Abstract

SERINC5 is a multipass intrinsic membrane protein that suppresses HIV-1 infectivity when incorporated into budding virions. The HIV-1 Nef virulence factor prevents viral incorporation of SERINC5 by triggering its down-regulation from the producer cell membrane through an AP-2-dependent endolysosomal pathway. However, the mechanistic basis for SERINC5 down-regulation by Nef remains elusive. Here we demonstrate that Nef homodimers are important for SERINC5 down-regulation, trafficking to late endosomes, and exclusion from newly synthesized viral particles. Based on previous X-ray crystal structures, we mutated three conserved residues in the Nef dimer interface (Leu112, Tyr115, and Phe121) and demonstrated attenuated homodimer formation in a cell-based fluorescence complementation assay. Point mutations at each position reduced the infectivity of HIV-1 produced from transfected 293T cells, the Jurkat TAg T-cell line, and donor mononuclear cells in a SERINC5-dependent manner. In SERINC5-transfected 293T cells, virion incorporation of SERINC5 was increased by dimerization-defective Nef mutants, whereas down-regulation of SERINC5 from the membrane of transfected Jurkat cells by these mutants was significantly reduced. Nef dimer interface mutants also failed to trigger internalization of SERINC5 and localization to Rab7+ late endosomes in T cells. Importantly, fluorescence complementation assays demonstrated that dimerization-defective Nef mutants retained interaction with both SERINC5 and AP-2. These results show that down-regulation of SERINC5 and subsequent enhancement of viral infectivity require Nef homodimers and support a mechanism by which the Nef dimer bridges SERINC5 to AP-2 for endocytosis. Pharmacological disruption of Nef homodimers may control HIV-1 infectivity and viral spread by enhancing virion incorporation of SERINC5.
© 2020 Staudt and Smithgall.

Entities:  

Keywords:  HIV-1 Nef; SERINC5; adaptor protein complex 2; bimolecular fluorescence complementation (BiFC); dimerization; endocytosis; human immunodeficiency virus (HIV); infectious disease; infectivity; protein–protein interaction; restriction factor

Mesh:

Substances:

Year:  2020        PMID: 32873704      PMCID: PMC7667984          DOI: 10.1074/jbc.RA120.014668

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  A robust and scalable TCR-based reporter cell assay to measure HIV-1 Nef-mediated T cell immune evasion.

Authors:  Gursev Anmole; Xiaomei T Kuang; Mako Toyoda; Eric Martin; Aniqa Shahid; Anh Q Le; Tristan Markle; Bemuluyigza Baraki; R Brad Jones; Mario A Ostrowski; Takamasa Ueno; Zabrina L Brumme; Mark A Brockman
Journal:  J Immunol Methods       Date:  2015-08-28       Impact factor: 2.303

3.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

4.  Global landscape of HIV-human protein complexes.

Authors:  Stefanie Jäger; Peter Cimermancic; Natali Gulbahce; Jeffrey R Johnson; Kathryn E McGovern; Starlynn C Clarke; Michael Shales; Gaelle Mercenne; Lars Pache; Kathy Li; Hilda Hernandez; Gwendolyn M Jang; Shoshannah L Roth; Eyal Akiva; John Marlett; Melanie Stephens; Iván D'Orso; Jason Fernandes; Marie Fahey; Cathal Mahon; Anthony J O'Donoghue; Aleksandar Todorovic; John H Morris; David A Maltby; Tom Alber; Gerard Cagney; Frederic D Bushman; John A Young; Sumit K Chanda; Wesley I Sundquist; Tanja Kortemme; Ryan D Hernandez; Charles S Craik; Alma Burlingame; Andrej Sali; Alan D Frankel; Nevan J Krogan
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

5.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes.

Authors:  Richard D Sloan; Daniel A Donahue; Björn D Kuhl; Tamara Bar-Magen; Mark A Wainberg
Journal:  Retrovirology       Date:  2010-05-13       Impact factor: 4.602

7.  Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity.

Authors:  Lori A Emert-Sedlak; Purushottam Narute; Sherry T Shu; Jerrod A Poe; Haibin Shi; Naveena Yanamala; John Jeff Alvarado; John S Lazo; Joanne I Yeh; Paul A Johnston; Thomas E Smithgall
Journal:  Chem Biol       Date:  2013-01-24

8.  The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.

Authors:  Sreya Tarafdar; Jerrod A Poe; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2014-04-10       Impact factor: 5.157

9.  A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef.

Authors:  Weiwei Dai; Yoshiko Usami; Yuanfei Wu; Heinrich Göttlinger
Journal:  Cell Rep       Date:  2018-01-28       Impact factor: 9.423

10.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  5 in total

1.  An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.

Authors:  Mitchell J Mumby; Aaron L Johnson; Steven M Trothen; Cassandra R Edgar; Richard Gibson; Peter B Stathopulos; Eric J Arts; Jimmy D Dikeakos
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

Review 2.  HIV-1 restriction by SERINC5.

Authors:  Lucía Cano-Ortiz; Tom Luedde; Carsten Münk
Journal:  Med Microbiol Immunol       Date:  2022-03-25       Impact factor: 3.402

3.  Ubiquitin E3 Ligase c-Cbl Is a Host Negative Regulator of Nef Protein of HIV-1.

Authors:  Hong-Guang Zhang; Jing Guo; Yukang Yuan; Yibo Zuo; Jin Liu; Li Zhu; Ying Miao; Xiangjie Chen; Lincong Jin; Fan Huang; Tengfei Ren; Jiuyi He; Weifeng Shi; Zhenke Wen; Chuanwu Zhu; Hui Zheng; Chunsheng Dong; Feng Qian
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

Review 4.  Retroviral Restriction Factors and Their Viral Targets: Restriction Strategies and Evolutionary Adaptations.

Authors:  Guney Boso; Christine A Kozak
Journal:  Microorganisms       Date:  2020-12-11

5.  Cul3-KLHL20 E3 ubiquitin ligase plays a key role in the arms race between HIV-1 Nef and host SERINC5 restriction.

Authors:  Sunan Li; Rongrong Li; Iqbal Ahmad; Xiaomeng Liu; Silas F Johnson; Liangliang Sun; Yong-Hui Zheng
Journal:  Nat Commun       Date:  2022-04-26       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.